Skip to content
Lower risk Drug recall · FDA · Published October 23, 2023

Major Pharmaceuticals Phenytoin Oral Suspension Recall: Failed Content Uniformity

Major Pharmaceuticals recalls Phenytoin Oral Suspension due to failed content uniformity specifications. This may affect medication dosing accuracy. Contact for remedy details.

🇺🇸 FDA recall #D-0153-2024DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling Phenytoin Oral Suspension (100 mg/4 mL) because it failed content uniformity tests. This could lead to incorrect medication dosing, which is serious for patients using this anticonvulsant. Read more at govinfonow.com/recall/33032-major-pharmaceuticals-phenytoin-oral-suspension-recall-failed-content-uniformity.

Source Summary by GovInfoNow · govinfonow.com/recall/33032-major-pharmaceuticals-phenytoin-oral-suspension-recall-failed-content-uniformity · Updated August 17, 2026 · FDA enforcement record: FDA #D-0153-2024

Cite this page

“Major Pharmaceuticals Phenytoin Oral Suspension Recall: Failed Content Uniformity.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33032-major-pharmaceuticals-phenytoin-oral-suspension-recall-failed-content-uniformity. Based on FDA recall #D-0153-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0153-2024%22&limit=1).

The FDA announced on Oct. 23, 2023, that Major Pharmaceuticals and Rugby Laboratories are voluntarily recalling Phenytoin Oral Suspension due to failed content uniformity specifications. The Class I recall affects 3,718 saleable units distributed nationwide.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: Phenytoin Oral Suspension, USP, 100 mg/4 mL
  • Packaging: 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57)
  • Lot codes: C00099, C00115 (Exp. 07/31/2024); C00079 (Exp. 12/31/2023)

The hazard

The product failed content uniformity specifications, according to the FDA. The recall is classified as Class I.

Context

GovInfoNow's records show the brand has 14 other recalls on record since May 31, 2023. Other recent recalls of similar products include Major Chlorpromazine 50mg Tablets Recall (Sept. 12, 2025), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (Sept. 2, 2025), and Major Pharmaceuticals Carvedilol Tablets Recall (Aug. 20, 2025).

How to tell if you have this one

Check for the product name 'Phenytoin Oral Suspension, USP, 100 mg/4 mL' in 4 mL unit dose cups. Look for lot numbers C00099, C00115 (expiring 07/31/2024) or C00079 (expiring 12/31/2023).

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the packaging to confirm if it's in the recalled batch.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Oct 23, 202312. FDA classified it Class I: Dec 20, 202323. Published in FDA’s Enforcement Report: Dec 27, 202334. FDA terminated the recall: Jul 10, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0153-2024 (October 23, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0153-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.